Project REACH: A Comprehensive Telehealth Intervention at Syringe Service Programs to Engage People Who Use Drugs
1 other identifier
interventional
121
1 country
1
Brief Summary
This trial will assess the feasibility, acceptability, and preliminary effectiveness of Project REACH (Remote Engagement \& Access for Community Health), a telehealth intervention at syringe service programs (SSP) to improve access to HIV-related evidence-based interventions (EBI) for people who use drugs including those who inject them.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 19, 2026
CompletedFirst Posted
Study publicly available on registry
February 25, 2026
CompletedStudy Start
First participant enrolled
May 6, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2028
May 19, 2026
May 1, 2026
2 years
February 19, 2026
May 18, 2026
Conditions
Outcome Measures
Primary Outcomes (4)
Recruitment and Retention Rates
Proportion of enrolled participants who complete the study
Year 2
Comfort Accessing Telehealth Services
Assessed in exit interviews
Year 2
Uptake of PrEP
EPIC Smartforms
Year 2
Uptake of MOUD
EPIC Smartforms
Year 2
Study Arms (1)
Project REACH Intervention
EXPERIMENTALThe primary interactions with participants of Project REACH will consist of syringe service program (SSP)-based recruitment and enrollment, provision of telehealth services at SSPs for the 6-month pilot duration, and exit interviews with a subset of participants and SSP study staff following the trial.
Interventions
The primary interactions with participants of Project REACH will consist of SSP-based recruitment and enrollment, provision of telehealth services at SSPs for the 6-month pilot duration, and exit interviews with a subset of participants and SSP study staff following the trial.
Eligibility Criteria
You may qualify if:
- years of age or older
- able to speak and understand English
- have used an illicit substance at least once in the past year
- have lived in the study area (in or near their city of their recruitment) for at least 6 months
- have active health insurance by the start of the Project REACH trial date
You may not qualify if:
- Unable or unwilling to provide informed consent
- years of age or older
- able to speak and understand English
- currently employed or volunteering with the PCC or an SSP enrollment site for at least one year at the time of the interview OR hired as a study navigator at one of the four enrollment sites
- Unable or unwilling to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Minnesota
Minneapolis, Minnesota, 55455, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 19, 2026
First Posted
February 25, 2026
Study Start
May 6, 2026
Primary Completion (Estimated)
May 1, 2028
Study Completion (Estimated)
May 1, 2028
Last Updated
May 19, 2026
Record last verified: 2026-05